Kura Oncology, Inc (KURA) insider trading
Every open-market stock purchase and sale by Kura Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Troy Edward Wilson (CEO) bought $2.4M in the last 90 days, growing their stake 36%.
- Teresa Brophy Bair (C-suite exec) and 5 others sold $1.7M in the last 90 days.
Last 12 months: insiders bought $2.4M (2 buys) and sold $3.8M (26 sales). Last close $9.86 on Oct 22, 2026.
Recent KURA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 29, 2026 | Mollie Leoni (C-suite exec) | Sold | $310K |
| Sep 29, 2026 | Brian T. Powl (C-suite exec) | Sold | $166K |
| Sep 29, 2026 | Kathleen Ford (COO) | Sold | $39.4K |
| Sep 28, 2026 | Mollie Leoni (C-suite exec) | Sold | $131K |
| Sep 28, 2026 | Brian T. Powl (C-suite exec) | Sold | $94.7K |
| Sep 28, 2026 | Teresa Brophy Bair (C-suite exec) | Sold | $88.6K |
| Sep 28, 2026 | Brian T. Powl (C-suite exec) | Sold | $84.5K |
| Sep 28, 2026 | Kathleen Ford (COO) | Sold | $72.5K |
| Sep 28, 2026 | Thomas James Doyle (VP) | Sold | $48.4K |
| Sep 24, 2026 | Francis Burrows (C-suite exec) | Sold | $225K |
| Sep 24, 2026 | Francis Burrows (C-suite exec) | Bought (not open market) | $185K |
| Sep 24, 2026 | Francis Burrows (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Jennifer Fulk (CFO) | Bought (not open market) | — |
| Aug 24, 2026 | Troy Edward Wilson (CEO) | Bought | $1.2M |
| Aug 21, 2026 | Brian T. Powl (C-suite exec) | Sold | $51.7K |
| Aug 19, 2026 | Teresa Brophy Bair (C-suite exec) | Sold | $398K |
| Aug 17, 2026 | Troy Edward Wilson (CEO) | Bought | $1.1M |
| Jun 18, 2026 | Mollie Leoni (C-suite exec) | Sold | $834K |
| Jun 4, 2026 | Helen Louise Collins (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Faheem Hasnain (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Thomas Malley (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Mary T Szela (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Carol Schafer (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Michael Vasconcelles (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Diane L. Parks (Insider) | Bought (not open market) | — |
Who's trading KURA
- Kathleen Ford, COO: sold $225K (5 sales), last Sep 29, 2026
- Brian T. Powl, C-suite exec: sold $663K (9 sales), last Sep 29, 2026
- Mollie Leoni, C-suite exec: sold $1.5M (8 sales), last Sep 29, 2026
- Teresa Brophy Bair, C-suite exec: sold $701K (7 sales), last Sep 28, 2026
- Thomas James Doyle, VP: sold $141K (6 sales), last Sep 28, 2026
- Francis Burrows, C-suite exec: sold $468K (3 sales), last Sep 24, 2026
- Jennifer Fulk, CFO: other filings, last Sep 8, 2026
- Troy Edward Wilson, CEO: bought $2.4M (2 buys), last Aug 24, 2026
- Thomas Malley, Insider: other filings, last Jun 4, 2026
- Carol Schafer, Insider: other filings, last Jun 4, 2026
- Mary T Szela, Insider: other filings, last Jun 4, 2026
- Michael Vasconcelles, Insider: other filings, last Jun 4, 2026
- Diane L. Parks, Insider: other filings, last Jun 4, 2026
- Faheem Hasnain, Insider: sold $110K (1 sale), last Jun 4, 2026
- Helen Louise Collins, Insider: other filings, last Jun 4, 2026
Get free alerts when an insider at Kura Oncology, Inc files a new trade →